Global Fatty Liver Day convenes physicians, advocates, and other experts to share the latest insights on how to prevent, diagnose, and manage fatty liver disease. An informed worldwide community is essential to reduce the global prevalence of fatty liver disease, which can advance dangerously if left undetected and unacknowledged. Patients, caregivers, medical providers, policymakers, and all other advocates will learn actionable ways to support patients already diagnosed with fatty liver disease and to seek methods of risk reduction.


Breaking Barriers in Diagnosis

Join Global Liver Institute and Liver Coalition of San Diego for an important discussion on early detection and diagnosis of MASH. Learn how early risk-stratification, better referral pathways, and emerging treatment options, such as FDA-approved therapies for F2/F3 fibrosis, are improving outcomes and helping patients avoid progression to cirrhosis. This educational forum highlights practical strategies for clinicians, advocates, and community leaders working to advance liver health.

Fatty Liver Disease: Are you at risk?

There are many common risk factors for developing fatty liver disease, but it can be paused or reversed. Learn more in this animated video & talk to your doctor about getting screened is it right for you.

The Global State of Fatty Liver Disease

Explore the current landscape of fatty liver disease through the lens of leading experts in research, and clinical care in our keynote panel Global State of Fatty Liver Disease. This dynamic group of experts will highlight innovations in care, barriers to equitable access, and actionable strategies for advancing screening, diagnosis, and treatment worldwide.

What to Eat and Drink: A Practical Approach to Liver Health

Join The Association of Black Gastroenterologists and Hepatologists (ABGH) for an educational session and a live cooking demo to provide viewers with real-world, practical, and culturally-conscious information about what and what not to eat and drink to support liver health.

 

2024 Panels & Videos

Healing Your Liver: What Communities of Faith Need to Know About Liver Disease

The State of Fatty Liver Disease: Voices of Global Leaders

Combating Fatty Liver Disease: Advancing Awareness and Scaling Efforts


2023 Panels & Videos


2022 Panels


2021 Panels

NASH as a Global Public Health Challenge

NASH and Liver Cancer

NASH and Obesity

Pediatric NASH

NASH and Diabetes

Beyond the Biopsy: Innovations in Diagnostics

NASH in Lean Individuals

NASH: A Conversation in the Black Community


 
 

2020 Panels

NASH and Metabolic Syndrome

Beyond the Biopsy: The Role of NITs in NASH

If you have diabetes, are you being screened for fatty liver and NASH? Learn why you should be. Moderator Dennis Cryer, MD, FAHA Board of Directors, Global L...
Is liver biopsy still a gold standard? Was it ever? Learn about 21st century options. Moderator Donna Cryer, JD President and CEO, Global Liver Institute Was...

Pediatric NASH

NASH and Obesity

10% of American children have a fatty liver. What questions should you and your pediatrician be asking? Moderator Jeff McIntyre, MA NASH Program Director, Gl...
Your weight can impact your heart, joints, and liver. Learn more about the links between obesity and NASH. Moderator Donna Cryer, JD President and CEO, Globa...

NASH as a Global Public Health Challenge

NASH and Liver Cancer

NASH is still a global health threat for millions during the covid-19 pandemic. Learn what we all need to do. Moderator Donna Cryer, JD President and CEO, Gl...
Did you know that obesity and liver diseases like NASH are top drivers of cancer? Learn about who should be screened and how. Moderators Donna Cryer, JD Pres...

 
 

Partner Videos

Role of Lifestyle Modification in Management of NAFLD: Myth or reality? A Webinar by King’s College

The Patient Perspectives on NASH Trials & Disease Management - King's College

The Austrian Perspective on Fatty Liver Disease

Video Día Internacional del Hígado Graso Inglés

Swiss NASH Foundation

 
 

2018-2019 Videos

Learn about NASH, what is it, who is most at risk, best methods for detection and diagnosis, and hear from a patient who has been on this journey and has a successful outcome with Donna Cryer, President & CEO of Global Liver Institute, physician investigator Dr. Nadege T. Gunn, MD, and liver patient advocate Kimberly Martinez

Hear from Donna Cryer, President & CEO of Global Liver Institute, as she interviews physician investigator Dr. Nadege T. Gunn, MD, and liver patient advocate Kimberly Martinez.

How common is it?

Who is at risk?

Getting diagnosed

NASH patient care and clinical management

Uploaded by Global Liver Institute on 2019-06-04.

NASH perspectives